Free Republic

The Wim Hof method may produce a beneficial anti-inflammatory response characterized by increased epinephrine levels and a reduction in pro-inflammatory cytokines, according to a systematic review published in the open-access journal PLOS ONE. The Wim Hof method is touted by founder and extreme athlete Wim Hof as a practical way to improve physical and mental health. It consists of three pillars—the Wim Hof breathing method, cold therapy, and commitment. Several studies have assessed the impact of the Wim Hof method on immune and stress responses, exercise performance, and psychological responses, but independent studies are generally too small to draw clear...

Big Pharma did not like Donald Trump, but they certainly like Joe Biden – especially now. In an ongoing frenzy to undo everything Trump did over the last four years, Joe Biden froze a December rule aimed at lowering prescription drug prices for insulin and epinephrine. On Thursday, Biden’s Department of Health and Human Services announced the new rule would be put on hold, along with several other Trump-era orders pending a 60 day review, The Federalist reports. Biden Chief of Staff Ron Klain directed federal agencies on Wednesday to pause orders that had been signed and published by Trump’s...

President Joe Biden’s United States Department of Health and Human Services (HHS) on Thursday stopped executive orders from his predecessor designed to significantly lower prescription drug prices for Americans, including insulin and epinephrine. The new administration will apparently re-evaluate the executive action from President Donald Trump toward the end of March. It remains unclear if it will be reinstated. “The HHS Thursday froze the former Trump administration’s December drug policy that requires community health centers to pass on all their insulin and epinephrine discount savings to patients,” Bloomberg Law reported Thursday. “Centers that don’t pass on the savings wouldn’t qualify...

Mylan to Launch a Lower Cost Generic EpiPenUpdated Sept. 1: Mylan announced on Aug. 29 that it will launch a generic version of its EpiPen at half the cost of the patented original. It plans to introduce a generic two-pack of auto-injectors for $300, compared to the list price of $609 on the branded auto-injector set. Facing relentless pressure from politicians, the media and social media over steep increases on EpiPens, this was the second move Mylan has made on auto-injector pricing in less than a week. Given that the EpiPen brand still has patent protection, the generic announcement...

AllergicLiving: Inside the EpiPen Price Backlash Amid a firestorm of controversy over price hikes on lifesaving EpiPens, drug manufacturer Mylan made a dramatic and unusual move this week – it announced the launch of a lower cost generic replica of its brand-name epinephrine auto-injector. Mylan has been under relentless pressure over the pricing of its EpiPen epineprhine auto-injectors since it surfaced that the list price for a set of two devices reached $609 in May 2016, an increase of more than 500 percent from 2008. To alleviate widespread sticker shock at pharmacy counters, Mylan CEO Heather Bresch’s initial response...

Hillary feigns outrage, but everything about this has Democrat fingerprints on it Just like earlier this year with Martin Shkreli and Daraprim, the Internet is full of outrage the past few days over the action of Mylan CEO Heather Fausch to raise the price of the live-saving drug EpiPen to $500 per unit. And as always happens, politicians are getting into the act, particularly Hillary Clinton, who raged that Mylan must reduce the price immediately - as if pharmaceutical companies check with candidates for political office in setting their pricing. But if Hillary really wants to manifest her rage -...

A couple of years ago, I got my front teeth knocked out by a combination of bad decisions and gravity. I had never so much as seen the inside of a dentist’s office, so I didn’t really know what to expect. The reality was amazing: I went to a tiny little office a few blocks down from National Review’s palatial penthouse at Buckley Towers, where a lovely young Indian immigrant gazed into my mug and compared some enamels samples like a painter trying to decide whether your living room is actually “Westhighland white” or more of a “Restoration ivory,” and...

CEO who gouged price of EpiPen is daughter of Democrat senator CHARLESTON, W.Va. — As a pharmaceutical company run by U.S. Sen. Joe Manchin’s daughter faces scrutiny for hiking prices on life-saving allergy injection pens, Manchin is remaining mum. The Democratic West Virginia senator’s daughter, Heather Bresch, is CEO of Mylan, which manufactures EpiPens. A two-dose package cost around $94 nine years ago. The cost averaged more than six times that in May. Manchin spokesman Jonathan Kott said Wednesday the senator had no comment.

As a pharmaceutical company run by U.S. Sen. Joe Manchin's daughter faces scrutiny for hiking prices on life-saving allergy injection pens, Manchin is remaining mum. The Democratic West Virginia senator's daughter, Heather Bresch, is CEO of Mylan, which manufactures EpiPens.

Washington (CNN)The incredible increase in the cost of EpiPens, auto-injectors that can stop life-threatening emergencies caused by allergic reactions, has hit home on Capitol Hill, where one Democratic senator whose daughter has allergies has called for action and another Democratic senator's daughter is CEO of the company responsible for the price hike. Sen. Amy Klobuchar of Minnesota, a Democrat whose daughter relies on EpiPen, urged the Senate Judiciary Committee to investigate the price increase of the medication, calling it "unjustified." Meanwhile, the daughter of Sen. Joe Manchin, the Democrat of West Virginia, has a very different personal connection. His daughter...

Sanofi US Issues Voluntary Nationwide Recall of Auvi‑Q® Due to Potential Inaccurate Dosage Delivery Sanofi US is voluntarily recalling all Auvi‑Q® (epinephrine injection, USP). The recall involves all Auvi‑Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for hospitals, retailers and consumers. This includes lot number 2299596 through 3037230, which expire March 2016 through December 2016. The products have been found to potentially have inaccurate dosage delivery. If a patient experiencing a serious allergic reaction (i.e., anaphylaxis) did not receive the intended dose, there could be significant health consequences, including death because anaphylaxis...

Obama Administration to Ban Asthma Inhalers Over Environmental Concerns 3:00 PM, Sep 23, 2011 • By MARK HEMINGWAY Single Page Print Larger Text Smaller Text Alerts Remember how Obama recently waived new ozone regulations at the EPA because they were too costly? Well, it seems that the Obama administration is would rather make people with Asthma cough up money than let them make a surely inconsequential contribution to depleting the ozone layer: Asthma patients who rely on over-the-counter inhalers will need to switch to prescription-only alternatives as part of the federal government's latest attempt to protect the Earth's atmosphere. The...